血液グループ化試薬の世界市場 2024-2028

血液グループ化試薬市場は2023-2028年に5億2,068万米ドル、予測期間中のCAGRは8.13％で成長すると予測されます。

当レポートでは、血液グループ化試薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、献血の増加、病院や血液バンクの数の増加によって牽引されています。

本調査では、診断機器の進歩が今後数年間の血液グループ化試薬市場成長を牽引する主要因の1つであるとしています。また、血液型分類におけるマルチプレックスアッセイの採用拡大、自動化とハイスループットプラットフォームの統合は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 血液グループ化試薬の世界市場 2018-2022
• エンドユーザーセグメント分析 2018-2022
• テクニックセグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院と血液バンク：市場規模と予測 2023-2028
• 臨床検査室：市場規模と予測 2023-2028
• 学術研究機関：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：技術別

• 市場セグメント
• 比較：技術別
• PCRベースとマイクロアレイ技術：市場規模と予測 2023-2028
• アッセイベースの技術：市場規模と予測 2023-2028
• 超並列シーケンシング技術：市場規模と予測 2023-2028
• 血清学：市場規模と予測 2023-2028
• 市場機会：技術別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• フランス：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AliveDX
• Arena Bio Scien
• ARKRAY Inc.
• Atlas Medical GmbH
• Bio Rad Laboratories Inc.
• Calibre Scientific Inc.
• Danaher Corp.
• DIAGAST SAS
• Grifols SA
• Merck KGaA
• Novacyt SA
• Paragon Care Ltd.
• QuidelOrtho Corp.
• Thermo Fisher Scientific Inc.
• Tulip Diagnostics Pvt. Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Technique
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global blood-grouping reagents market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Technique Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Hospitals and blood banks - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Hospitals and blood banks - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by End-user ($ million)
• Exhibits47: Data Table on Market opportunity by End-user ($ million)
• Exhibits48: Chart on Technique - Market share 2023-2028 (%)
• Exhibits49: Data Table on Technique - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Technique
• Exhibits51: Data Table on Comparison by Technique
• Exhibits52: Chart on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on PCR-based and microarray techniques - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on PCR-based and microarray techniques - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Assay-based techniques - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Assay-based techniques - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Assay-based techniques - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Massively parallel sequencing techniques - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Massively parallel sequencing techniques - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Serology - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Serology - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Serology - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Serology - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Technique ($ million)
• Exhibits69: Data Table on Market opportunity by Technique ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: AliveDX - Overview
• Exhibits120: AliveDX - Product / Service
• Exhibits121: AliveDX - Key offerings
• Exhibits122: Arena Bio Scien - Overview
• Exhibits123: Arena Bio Scien - Product / Service
• Exhibits124: Arena Bio Scien - Key offerings
• Exhibits125: ARKRAY Inc. - Overview
• Exhibits126: ARKRAY Inc. - Product / Service
• Exhibits127: ARKRAY Inc. - Key offerings
• Exhibits128: Atlas Medical GmbH - Overview
• Exhibits129: Atlas Medical GmbH - Product / Service
• Exhibits130: Atlas Medical GmbH - Key offerings
• Exhibits131: Bio Rad Laboratories Inc. - Overview
• Exhibits132: Bio Rad Laboratories Inc. - Business segments
• Exhibits133: Bio Rad Laboratories Inc. - Key news
• Exhibits134: Bio Rad Laboratories Inc. - Key offerings
• Exhibits135: Bio Rad Laboratories Inc. - Segment focus
• Exhibits136: Calibre Scientific Inc. - Overview
• Exhibits137: Calibre Scientific Inc. - Product / Service
• Exhibits138: Calibre Scientific Inc. - Key offerings
• Exhibits139: Danaher Corp. - Overview
• Exhibits140: Danaher Corp. - Business segments
• Exhibits141: Danaher Corp. - Key news
• Exhibits142: Danaher Corp. - Key offerings
• Exhibits143: Danaher Corp. - Segment focus
• Exhibits144: DIAGAST SAS - Overview
• Exhibits145: DIAGAST SAS - Product / Service
• Exhibits146: DIAGAST SAS - Key offerings
• Exhibits147: Grifols SA - Overview
• Exhibits148: Grifols SA - Business segments
• Exhibits149: Grifols SA - Key offerings
• Exhibits150: Grifols SA - Segment focus
• Exhibits151: Merck KGaA - Overview
• Exhibits152: Merck KGaA - Business segments
• Exhibits153: Merck KGaA - Key news
• Exhibits154: Merck KGaA - Key offerings
• Exhibits155: Merck KGaA - Segment focus
• Exhibits156: Novacyt SA - Overview
• Exhibits157: Novacyt SA - Business segments
• Exhibits158: Novacyt SA - Key offerings
• Exhibits159: Novacyt SA - Segment focus
• Exhibits160: Paragon Care Ltd. - Overview
• Exhibits161: Paragon Care Ltd. - Business segments
• Exhibits162: Paragon Care Ltd. - Key offerings
• Exhibits163: Paragon Care Ltd. - Segment focus
• Exhibits164: QuidelOrtho Corp. - Overview
• Exhibits165: QuidelOrtho Corp. - Product / Service
• Exhibits166: QuidelOrtho Corp. - Key offerings
• Exhibits167: Thermo Fisher Scientific Inc. - Overview
• Exhibits168: Thermo Fisher Scientific Inc. - Business segments
• Exhibits169: Thermo Fisher Scientific Inc. - Key news
• Exhibits170: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits171: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits172: Tulip Diagnostics Pvt. Ltd. - Overview
• Exhibits173: Tulip Diagnostics Pvt. Ltd. - Product / Service
• Exhibits174: Tulip Diagnostics Pvt. Ltd. - Key offerings
• Exhibits175: Inclusions checklist
• Exhibits176: Exclusions checklist
• Exhibits177: Currency conversion rates for US$
• Exhibits178: Research methodology
• Exhibits179: Validation techniques employed for market sizing
• Exhibits180: Information sources
• Exhibits181: List of abbreviations

The blood-grouping reagents market is forecasted to grow by USD 520.68 mn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the blood-grouping reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic disorders, rise in blood donations, and a growing number of hospitals and blood banks.

Technavio's blood-grouping reagents market is segmented as below:

By End-user

• Hospitals and blood banks
• Clinical laboratories
• Academic and research institutes

By Technique

• PCR-based and microarray techniques
• Assay-based techniques
• Massively parallel sequencing techniques
• Serology

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancements in diagnostic devices as one of the prime reasons driving the blood-grouping reagents market growth during the next few years. Also, the growing adoption of multiplexing assays and integration of automation and high-throughput platforms in blood grouping will lead to sizable demand in the market.

The report on the blood-grouping reagents market covers the following areas:

• Blood-grouping reagents market sizing
• Blood-grouping reagents market forecast
• Blood-grouping reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood-grouping reagents market vendors that include AliveDX, Arena Bio Scien, ARKRAY Inc., Atlas Medical GmbH, BAG Health Care GmbH, Bio Rad Laboratories Inc., Calibre Scientific Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Merck KGaA, Novacyt SA, QuidelOrtho Corp., Rapid Labs Ltd., Thermo Fisher Scientific Inc., Torax Biosciences Ltd., Tulip Diagnostics Pvt. Ltd., Fortress Diagnostics, Paragon Care Ltd., and VitroScient. Also, the blood-grouping reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global blood-grouping reagents market 2018 - 2022
• 4.2 End-User Segment Analysis 2018 - 2022
• 4.3 Technique Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by End-user

• 6.1 Market segments
• 6.2 Comparison by End-user
• 6.3 Hospitals and blood banks - Market size and forecast 2023-2028
• 6.4 Clinical laboratories - Market size and forecast 2023-2028
• 6.5 Academic and research institutes - Market size and forecast 2023-2028
• 6.6 Market opportunity by End-user

7 Market Segmentation by Technique

• 7.1 Market segments
• 7.2 Comparison by Technique
• 7.3 PCR-based and microarray techniques - Market size and forecast 2023-2028
• 7.4 Assay-based techniques - Market size and forecast 2023-2028
• 7.5 Massively parallel sequencing techniques - Market size and forecast 2023-2028
• 7.6 Serology - Market size and forecast 2023-2028
• 7.7 Market opportunity by Technique

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 UK - Market size and forecast 2023-2028
• 9.9 Canada - Market size and forecast 2023-2028
• 9.10 France - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 AliveDX
• 12.4 Arena Bio Scien
• 12.5 ARKRAY Inc.
• 12.6 Atlas Medical GmbH
• 12.7 Bio Rad Laboratories Inc.
• 12.8 Calibre Scientific Inc.
• 12.9 Danaher Corp.
• 12.10 DIAGAST SAS
• 12.11 Grifols SA
• 12.12 Merck KGaA
• 12.13 Novacyt SA
• 12.14 Paragon Care Ltd.
• 12.15 QuidelOrtho Corp.
• 12.16 Thermo Fisher Scientific Inc.
• 12.17 Tulip Diagnostics Pvt. Ltd.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations